About Quantificare
Quantificare is a company based in San Mateo (United States) founded in 2001. Quantificare has raised $5.49 million across 1 funding round from investors including LBO France. Quantificare offers products and services including LifeViz Mini Pro, LifeViz Infinity Pro, LifeViz Mini, LifeViz Infinity, and LifeViz Body. Quantificare operates in a competitive market with competitors including BioTelemetry, Oncodesign Services, Calyx, Molecular NeuroImaging and Imaging Endpoints, among others.
- Headquarter San Mateo, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Quantificare Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.49 M (USD)
in 1 rounds
-
Latest Funding Round
$5.49 M (USD), Series A
Sep 03, 2019
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quantificare
Quantificare offers a comprehensive portfolio of products and services, including LifeViz Mini Pro, LifeViz Infinity Pro, LifeViz Mini, LifeViz Infinity, and LifeViz Body.
3D system for facial and body imaging in aesthetic practices.
Advanced 3D photography for detailed patient consultations.
Compact tool for aesthetic image capture and analysis.
3D imaging device for comprehensive body assessments.
Specialized system for body and breast imaging applications.
Micro-level 3D imaging for clinical trial evaluations.
Services for study setup and image analysis in trials.
People of Quantificare
Unlock access to complete
Funding Insights of Quantificare
Quantificare has successfully raised a total of $5.49M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.49 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Quantificare
Quantificare has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include LBO France.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are made in France and the US.
|
Locked | Locked | Locked |
Investor details for Quantificare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quantificare
Investment portfolio details for Quantificare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Quantificare
Detailed financials for Quantificare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quantificare Comparisons
Peer comparison for Quantificare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quantificare
Quantificare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioTelemetry, Oncodesign Services, Calyx, Molecular NeuroImaging and Imaging Endpoints, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wireless products for monitoring health parameters are offered.
|
|
| Locked | Locked | Locked |
CRO focused on oncology drugs discovery, bioanalysis, and preclinical services
|
|
| Locked | Locked | Locked |
CRO providing imaging services for clinical development
|
|
| Locked | Locked | Locked |
Company offering specialized imaging services for neurodegenerative and neuropsychiatric disorders
|
|
| Locked | Locked | Locked |
Offers medical imaging expertise for oncology research and clinical trials globally.
|
Detailed competitors of Quantificare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quantificare
Complete news archive for Quantificare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quantificare
Quantificare was founded in 2001 and raised its 1st funding round 18 years after it was founded.
Quantificare is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Quantificare is a funded company, having raised a total of $5.49M across 1 funding round to date.
Provider of 3D imaging systems and clinical trial services for aesthetic and medical applications. It offers a suite of 3D cameras for aesthetic practitioners to capture and track patient progress. Additionally, it provides comprehensive clinical trial imaging services, including study setup, image management, analysis, and independent panel review. These services support pharmaceutical, biotechnology, and medical device companies in evaluating treatment efficacy and safety. The companys offerings are designed to standardize imaging processes and improve the accuracy of assessments in both clinical and aesthetic settings.
Quantificare's top competitors include BioTelemetry, Oncodesign Services and Calyx.
Quantificare offers LifeViz Mini Pro, LifeViz Infinity Pro, LifeViz Mini, LifeViz Infinity, and 3 more products and services.
Quantificare has 1 investor. Key investors include LBO France.